Identifying a risk profile for thyroid cancer

Yousem DM, 1997, Clinical and economic impact of incidental thyroid lesions found with CT and MR, AJNR, 18, 1423

Ezzat S, 1994, Thyroid incidentalomas: Prevalence by palpation and ultrasonography, Arch Intern Med, 154, 1838, 10.1001/archinte.1994.00420160075010

Davies L, 2006, Increasing incidence of thyroid cancer in the United States, 1973-2002, JAMA, 295, 2164, 10.1001/jama.295.18.2164

Harach HR, 1985, Occult papillary carcinoma of the thyroid: A "normal" finding in Finland. A systemic autopsy study, Cancer, 56, 531, 10.1002/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3

Franssila KO, 1986, Occult papillary carcinoma of the thyroid in children and young adults: A systemic autopsy study in Finland, Cancer, 58, 715, 10.1002/1097-0142(19860801)58:3<715::AID-CNCR2820580319>3.0.CO;2-P

Lang W, 1988, Occult carcinomas of the thyroid: Evaluation of 1020 sequential autopsies, Am J Clin Pathol, 40, 72, 10.1093/ajcp/90.1.72

Martinez-Tello FJ, 1993, Occult carcinoma of the thyroid: A systematic autopsy study from Spain of two series performed with two different methods, Cancer, 71, 4022, 10.1002/1097-0142(19930615)71:12<4022::AID-CNCR2820711236>3.0.CO;2-O

Hefer TH, 1995, Highly aggressive behaviour of occult papillary thyroid carcinoma, J J Laryngol Otol, 109, 1109, 10.1017/S0022215100132165

Nogushi S, 1996, Small carcinoma of the thyroid: A long-term follow-up of 867 patients, Arch Surg, 131, 187, 10.1001/archsurg.1996.01430140077021

Fink A, 1996, Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms, Mod Pathol, 9, 816

Mitselou A, 2002, Occult thyroid carcinoma: A study of 160 autopsy cases. The first report for the region of Epirus-Greece, Anticancer Res, 22, 427

Coeli CM, 2005, Incidence and mortality from thyroid cancer in Brazil, Arq Bras Endocrinol Metab, 49, 503

de Matos PS, 2006, Prevalence of papillary microcarcinoma of the thyroid in Brazilian autopsy and surgical series, Endocr Pathol, 17, 165, 10.1385/EP:17:2:165

Chan EK, 2006, A hormonal association between estrogen metabolism and proliferative thyroid disease, Otolaryngol Head Neck Surg, 134, 893, 10.1016/j.otohns.2006.01.020

Ward LS, 2007, The impact of gender in differentiated thyroid cancer, Clin Endocrinol, 66, 752, 10.1111/j.1365-2265.2007.02789.x

Mazzaferri EL, 2001, Current approaches to primary therapy for papillary and follicular thyroid cancer, J Clin Endocrinol Metab, 86, 1447, 10.1210/jcem.86.4.7407

Vivacqua A, 2006, 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the G protein-coupled receptor GPR30, Mol Pharmacol, 70, 1414, 10.1124/mol.106.026344

Wada N, 2007, Prognostic value of the sixth edition AJCC/UICC TNM classification for differentiated thyroid carcinoma with extrathyroid extension, J Clin Endocrinol Metab, 92, 215, 10.1210/jc.2006-1443

Shaha AR, 2007, TNM classification of thyroid carcinoma, World J Surg, 31, 879, 10.1007/s00268-006-0864-0

Ward LS, 2007, Commonly used prognostic scoring systems are not adequate to predict the outcome of papillary microcarcinomas of the thyroid, J Sur Onco

Ward LS, 2004, Thyroid cancer: prognostic factors and treatment, Arq Bras Endocrinol Metab, 48, 126

Lundgren CI, 2006, Are possible risk factors for differentiated thyroid cancer of prognostic importance?, Thyroid, 16, 659, 10.1089/thy.2006.16.659

Russell JP, 2004, Proinflammatory mediators and genetic background in oncogene mediated tumor progression, J Immunol, 172, 4059, 10.4049/jimmunol.172.7.4059

Souza SL, 2003, Impact of previous thyroid autoimmune diseases on prognosis of patients with well-differentiated thyroid cancer, Thyroid, 13, 491, 10.1089/105072503322021160

Mack WJ, 2003, A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea, Cancer Causes Control, 14, 773, 10.1023/A:1026349702909

Navarro Silvera SA, 2005, Risk factors for thyroid cancer: a prospective cohort study, Int J Cancer, 116, 433, 10.1002/ijc.21079

Bufalo NE, 2006, Smoking and susceptibility to thyroid cancer: an inverse association with CYP1A1 allelic variants, Endocr Relat Cancer, 13, 1185, 10.1677/ERC-06-0002

Barbaro D, 2005, Thyroid papillary cancers: microcarcinoma and carcinoma, incidental cancers and non-incidental cancers - are they different diseases?, Clin Endocrinol, 63, 577, 10.1111/j.1365-2265.2005.02386.x

Hefer TH, 1995, Highly aggressive behaviour of occult papillary thyroid carcinoma, J Laryngol Otol, 109, 1109, 10.1017/S0022215100132165

Livolsi VA, 1996, Highly aggressive behaviour of occult papillary thyroid carcinoma, J Laryngol Otol, 110, 10.1017/S0022215100134747

Farid NR, 1994, Molecular basis of thyroid cancer, Endocr Rev, 15, 202

Memon A, 2004, Family history of benign thyroid disease and cancer and risk of thyroid cancer, Eur J Cancer, 40, 754, 10.1016/j.ejca.2003.12.011

Schlumberger MJ, 2000, Papillary and follicular thyroid carcinoma, Baillieres Best Pract Res Clin Endocrinol Metab, 14, 601, 10.1053/beem.2000.0105

Kazakov VS, 1992, Thyroid cancer after Chernobyl, Nature, 359, 10.1038/359021a0

Lemoine NR, 1989, High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis, Oncogene, 4, 159

Grieco M, 1990, PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas, Cell, 60, 557, 10.1016/0092-8674(90)90659-3

Kimura ET, 2003, High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma, Cancer Res, 63, 1454

Kroll TG, 2000, PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma, Science, 289, 1357, 10.1126/science.289.5483.1357

Fagin JA, 1993, High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas, J Clin Invest, 91, 179, 10.1172/JCI116168

Ward LS, 1998, Studies of allelic loss in thyroid tumors reveal major differences in chromosomal instability between papillary and follicular carcinomas, J Clin Endocrinol Metab, 83, 525

Finn S, 2007, Low-level genomic instability is a feature of papillary thyroid carcinoma: an array comparative genomic hybridization study of laser capture microdissected papillary thyroid carcinoma tumors and clonal cell lines, Arch Pathol Lab Med, 131, 65, 10.5858/2007-131-65-LGIIAF

Demidchik EP, 1999, Thyroid cancer promoted by radiation in young people of Belarus

Jacob P, 2006, Thyroid cancer among Ukrainians and Belarusians who were children or adolescents at the time of the Chernobyl accident, J Radiol Prot, 26, 51, 10.1088/0952-4746/26/1/003

Imaizumi M, 2006, Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure, JAMA, 295, 1011, 10.1001/jama.295.9.1011

Ron E, 1995, Thyroid cancer after exposure to external radiation, a pooled analysis of 7 studies, Radiat Res, 141, 259, 10.2307/3579003

Williams ED, 2006, Chernobyl and thyroid cancer, J Surg Oncol, 94, 670, 10.1002/jso.20699

Feldt-Rasmussen U, 2001, Iodine and cancer, Thyroid, 11, 483, 10.1089/105072501300176435

Zafon C, 2007, Clinical significance of RET/PTC and p53 protein expression in sporadic papillary thyroid carcinoma, Histopathology, 50, 225, 10.1111/j.1365-2559.2006.02555.x

Jossart GH, 1996, Immunocytochemical detection of p53 in human thyroid carcinomas is associated with mutation and immortalization of cell lines, J Clin Endocrinol Metab, 81, 3498

Ward LS, 1998, Molecular genetics of thyroid cancer: evidence that inactivation of tumor suppressor genes occurs at late stages of tumor progression

Wreesmann VB, 2004, Genome-wide profiling of papillary thyroid cancer identifies MUC1 as an independent prognostic marker, Cancer Res, 64, 3780, 10.1158/0008-5472.CAN-03-1460

Patel KN, 2005, MUC1 plays a role in tumor maintenance in aggressive thyroid carcinomas, Surgery, 138, 994, 10.1016/j.surg.2005.09.030

Gilliland FD, 1997, Prognostic factors for thyroid carcinoma: A population-based study of 15,698 cases from the Surveillance, Epidemiology and End Results (SEER) program 1973-1991, Cancer, 79, 564, 10.1002/(SICI)1097-0142(19970201)79:3<564::AID-CNCR20>3.0.CO;2-0

Ward LS, 2003, Low expression of sodium iodide symporter identifies aggressive thyroid tumors, Cancer Let, 200, 85, 10.1016/S0304-3835(03)00392-6

Xing M, 2005, BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer, J Clin Endocrinol Metab, 90, 6373, 10.1210/jc.2005-0987

Kim TY, 2006, The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma, Clin Endocrinol, 65, 364, 10.1111/j.1365-2265.2006.02605.x

Fugazzola L, 2006, Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature, Endocr Relat Cancer, 13, 455, 10.1677/erc.1.01086

Capen CC, 1997, Mechanistic data and risk assessment of selected toxic end points of the thyroid gland, Toxicol Pathol, 25, 39, 10.1177/019262339702500109

Hard GC, 1998, Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis, Environ Health Perspect, 106, 427, 10.1289/ehp.106-1533202

Hurley PM, 1998, Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents, Environ Health Perspect, 106, 437, 10.1289/ehp.98106437

Schlumberger MJ, 2000, Papillary and follicular thyroid carcinoma, Baillieres Best Pract Res Clin Endocrinol Metab, 14, 601, 10.1053/beem.2000.0105

Hallquist A, 1994, Thyroid cancer: reproductive factors, previous diseases, drug intake, family history and diet. A case-control study, Eur J Cancer Prev, 3, 481, 10.1097/00008469-199411000-00005

Ries LAG, 2006

Ron E, 1987, A population-based case-control study of thyroid cancer, J Natl Cancer Inst, 79, 1

Haselkorn T, 2003, Why are thyroid cancer rates so high in Southeast Asian women living in the United States? The Bay Area thyroid cancer study, Cancer Epidemiol Biomark Prev, 12, 144

Mack WJ, 2002, Lifestyle and other risk factors for thyroid cancer in Los Angeles County females, Ann Epidemiol, 12, 395, 10.1016/S1047-2797(01)00281-2

Vineis P, 2003, Cancer as an evolutionary process at the cell level: an epidemiological perspective, Carcinogenesis, 24, 1, 10.1093/carcin/24.1.1

Lichtenstein P, 2000, Environmental and heritable factors in the causation of cancer, NEJM, 343, 78, 10.1056/NEJM200007133430201

Vineis P, 2001, An evolutionary paradigm for carcinogenesis?, J Epidemiol Community Health, 57, 89, 10.1136/jech.57.2.89

Autrup H, 2000, Genetic polymorphisms in human xenobiotic metabolizing enzymes as susceptibility factors in toxic response, Mutat Res, 464, 65, 10.1016/S1383-5718(99)00167-9

Clapper ML, 2000, Genetic polymorphism and cancer risk, Curr Oncol Rep, 2, 251, 10.1007/s11912-000-0075-z

Mannervik B, 1985, The isozymes of glutathione S-transferase, Adv Enzymol, 57, 357

Strange RC, 1999, The glutathione S-transferases: influence of polymorphism on cancer susceptibility, IARC Sci Publ, 148, 231

Morari EC, 2002, The null genotype of glutathione s-transferase M1 and T1 locus increases the risk for thyroid cancer, Cancer Epidemiol Biomark Prev, 11, 1485

Granja F, 2004, GST profiling may be useful in the screening for thyroid nodule malignancy, Cancer Lett, 209, 129, 10.1016/j.canlet.2003.12.013

Trindade ACG, 2006, Influência do gene N-Acetil Transferase 2 (NAT2) na susceptibilidade ao câncer da tiróide na população brasileira, Arq Bras Endocrinol Metab, 50, S238

Granja F, 2004, Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer, Cancer Lett, 210, 151, 10.1016/j.canlet.2004.01.016

Rogounovitch TI, 2006, TP53 codon 72 polymorphism in radiation-associated human papillary thyroid cancer, Oncol Rep, 15, 949

Bonora E, 2006, Novel germline variants identified in the inner mitochondrial membrane transporter TIMM44 and their role in predisposition to oncocytic thyroid carcinomas, Br J Cancer, 95, 1529, 10.1038/sj.bjc.6603455

Maximo V, 2005, Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hürthle cell) tumours of the thyroid, Br J Cancer, 92, 1892, 10.1038/sj.bjc.6602547

Baida A, 2005, Thyroid cancer susceptibility and THRA1 and BAT-40 repeats polymorphisms, Cancer Epidemiol Biomark Prev, 14, 638, 10.1158/1055-9965.EPI-04-0424

Cooper DS, 1998, Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry, Thyroid, 8, 737, 10.1089/thy.1998.8.737

Jonklaas J, 2006, Outcomes of patients with differentiated thyroid carcinoma following initial therapy, Thyroid, 16, 1229, 10.1089/thy.2006.16.1229

Verkooijen RB, 2007, A new functional parameter measured at the time of ablation that can be used to predict differentiated thyroid cancer recurrence during follow-up, Eur J Endocrinol, 156, 41, 10.1530/eje.1.02322

Eustatia-Rutten CF, 2004, Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis, Clin Endocrinol, 61, 61, 10.1111/j.1365-2265.2004.02060.x

Heemstra KA, 2007, Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma, Clin Endocrinol, 66, 58, 10.1111/j.1365-2265.2006.02685.x

King AD, 2000, Staging papillary carcinoma of the thyroid: magnetic resonance imaging vs. ultrasound of the neck, Clin Radiol, 55, 222, 10.1053/crad.1999.0373

Shetty SK, 2006, Significance of incidental thyroid lesions detected on CT: correlation among CT, sonography, and pathology, AJR Am J Roentgenol, 187, 1349, 10.2214/AJR.05.0468

Quon A, 2007, Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma, J Nucl Med, 48, 58S

Adam RL, 2006, The fractal dimension of nuclear chromatin as a prognostic factor in acute precursor B lymphoblastic leukemia, Cell Oncol, 28, 55

Lorand-Metze I, 2007, Detection of hematopoietic maturation abnormalities by flow cytometry in myelodysplastic syndromes and its utility for the differential diagnosis with non-clonal disorders, Leuk Res, 31, 147, 10.1016/j.leukres.2006.04.010

Delides A, 2005, Fractal dimension as a prognostic factor for laryngeal carcinoma, Anticancer Res, 25, 2141

Einstein AJ, 1998, Fractal characterization of chromatin appearance for diagnosis in breast cytology, J Pathol, 185, 366, 10.1002/(SICI)1096-9896(199808)185:4<366::AID-PATH122>3.0.CO;2-C

Ferreira RC, 2006, Application of the Minkowski-Bouligand fractal dimension for the differential diagnosis of thyroid follicular neoplasias, Cell Oncol, 28, 331

Florentine BD, 2006, Cost savings associated with the use of fine-needle aspiration biopsy (FNAB) for the diagnosis of palpable masses in a community hospital-based FNAB clinic, Cancer, 107, 2270, 10.1002/cncr.22234

Khalid AN, 2006, The cost-effectiveness of iodine 131 scintigraphy, ultrasonography, and fine-needle aspiration biopsy in the initial diagnosis of solitary thyroid nodules, Arch Otolaryngol Head Neck Surg, 132, 244, 10.1001/archotol.132.3.244